Workflow
Zenas Biopharma: A Risky Buy On Upcoming Data Readouts In IgG4, MS

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?This is my first time covering Zenas BioPharma, Inc. (NASDAQ: ZBIO ), a Waltham, Massachusetts based biotech that completed its initial public offering ("IPO") in September last year, raising $225m via the issuance ...